CytoDyn Inc. Induced Conversion of Convertible Debt Expense
CytoDyn Inc. (CYDY) reported Induced Conversion of Convertible Debt Expense of $6.69 million for the 12-month period ending 2022-05-31, per its 10-K filed 2023-09-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InducedConversionOfConvertibleDebtExpense · last filed 2023-09-14
- CytoDyn Inc. induced conversion of convertible debt expense for the quarter ending 2022-05-31 was $505.00K, a 49.50% decline year-over-year.
- CytoDyn Inc. induced conversion of convertible debt expense for the quarter ending 2022-02-28 was $954.00K, a 82.20% decline year-over-year.
- CytoDyn Inc. induced conversion of convertible debt expense for the quarter ending 2021-11-30 was $4.70M, a 11.55% increase year-over-year.
- CytoDyn Inc. induced conversion of convertible debt expense for the quarter ending 2021-08-31 was $528.00K, a 84.22% decline year-over-year.
- CytoDyn Inc. induced conversion of convertible debt expense for fiscal 2022 was $6.69M, a 51.94% decline from fiscal 2021.
- CytoDyn Inc. induced conversion of convertible debt expense for fiscal 2021 was $13.92M, a 40.60% decline from fiscal 2020.
- CytoDyn Inc. induced conversion of convertible debt expense for fiscal 2020 was $23.44M.
- CytoDyn Inc. induced conversion of convertible debt expense for fiscal 2016 was $1.19M, a 21.71% decline from fiscal 2015.
| Period end | Induced Conversion of Convertible Debt Expense 3 month | Induced Conversion of Convertible Debt Expense 3 month as first filed | Induced Conversion of Convertible Debt Expense 6 month | Induced Conversion of Convertible Debt Expense 9 month | Induced Conversion of Convertible Debt Expense 9 month as first filed | Induced Conversion of Convertible Debt Expense 12 month | Induced Conversion of Convertible Debt Expense 12 month as first filed | Induced Conversion of Convertible Debt Expense 121 month | Induced Conversion of Convertible Debt Expense 124 month |
|---|---|---|---|---|---|---|---|---|---|
| 2022-05-31 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-14 | $1.46M derived: sum of 2 quarters · filed 2023-09-14 | $6.16M derived: sum of 3 quarters · filed 2023-09-14 | $6.69M 10-K · filed 2023-09-14 | |||||
| 2022-02-28 | $954.00K 10-Q · filed 2023-04-10 | $5.66M derived: sum of 2 quarters · filed 2023-04-10 | $6.19M 10-Q · filed 2023-04-10 | $7.19M derived: sum of 4 quarters · filed 2023-04-10 | |||||
| 2021-11-30 | $4.70M 10-Q · filed 2023-01-09 | $5.23M 10-Q · filed 2023-01-09 | $6.23M derived: sum of 3 quarters · filed 2023-01-09 | $11.59M derived: sum of 4 quarters · filed 2023-01-09 | |||||
| 2021-08-31 | $528.00K 10-Q/A · filed 2022-10-13 | $9.00K 10-Q · filed 2021-10-12 | $1.53M derived: sum of 2 quarters · filed 2022-10-13 | $6.89M derived: sum of 3 quarters · filed 2022-10-13 | $11.11M derived: sum of 4 quarters · filed 2022-10-13 | ||||
| 2021-05-31 | $1.00M derived: 10-K 12 month − 10-K 9 month · filed 2022-08-15 | $6.36M derived: sum of 2 quarters · filed 2022-08-15 | $10.58M derived: sum of 3 quarters · filed 2022-08-15 | $13.92M 10-K · filed 2022-08-15 | $11.37M 10-K · filed 2021-07-30 | ||||
| 2021-02-28 | $5.36M 10-K · filed 2022-08-15 | $4.14M 10-Q · filed 2021-04-14 | $9.58M derived: sum of 2 quarters · filed 2022-08-15 | $12.92M 10-K · filed 2022-08-15 | $11.24M 10-Q · filed 2021-04-14 | $28.48M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2020-11-30 | $4.22M 10-K · filed 2022-08-15 | $7.56M 10-K · filed 2022-08-15 | $23.12M derived: sum of 3 quarters · filed 2022-08-15 | $28.29M derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2020-08-31 | $3.35M 10-Q · filed 2021-10-12 | $18.91M derived: sum of 2 quarters · filed 2022-08-15 | $24.07M derived: sum of 3 quarters · filed 2022-08-15 | ||||||
| 2020-05-31 | $15.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-15 | $20.72M derived: sum of 2 quarters · filed 2022-08-15 | $23.44M 10-K · filed 2022-08-15 | $7.90M 10-K · filed 2021-07-30 | |||||
| 2020-02-29 | $5.16M 10-Q · filed 2021-04-14 | $7.88M 10-Q · filed 2021-04-14 | |||||||
| 2019-05-31 | $4.73M 10-Q · filed 2022-01-10 | $196.00K 10-K · filed 2021-07-30 | |||||||
| 2016-05-31 | -$866.71K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-20 | -$429.44K derived: sum of 2 quarters · filed 2017-07-20 | $437.28K derived: sum of 3 quarters · filed 2017-07-20 | $1.19M 10-K · filed 2017-07-20 | $2.06M 10-K · filed 2016-07-19 | ||||
| 2016-02-29 | $437.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-13 | $1.30M derived: sum of 2 quarters · filed 2017-04-13 | $2.06M 10-Q · filed 2017-04-13 | $3.03M derived: sum of 4 quarters · filed 2017-04-13 | |||||
| 2015-11-30 | $866.71K 10-Q · filed 2017-01-13 | $1.62M 10-Q · filed 2017-01-13 | $2.60M derived: sum of 3 quarters · filed 2017-01-13 | $2.80M derived: sum of 4 quarters · filed 2017-01-13 | |||||
| 2015-08-31 | $757.87K 10-Q · filed 2016-10-12 | $1.73M derived: sum of 2 quarters · filed 2016-10-12 | $1.93M derived: sum of 3 quarters · filed 2016-10-12 | $2.28M derived: sum of 4 quarters · filed 2016-10-12 | |||||
| 2015-05-31 | $970.63K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-19 | $1.17M derived: sum of 2 quarters · filed 2016-07-19 | $1.53M derived: sum of 3 quarters · filed 2016-07-19 | $1.53M 10-K · filed 2016-07-19 | |||||
| 2015-02-28 | $202.29K 10-Q · filed 2016-04-13 | $555.63K derived: sum of 2 quarters · filed 2016-04-13 | $555.63K 10-Q · filed 2016-04-13 | ||||||
| 2014-11-30 | $353.33K 10-Q · filed 2016-01-11 | $353.33K 10-Q · filed 2016-01-11 | |||||||
| 2014-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-10 | $0.00 derived: sum of 2 quarters · filed 2015-07-10 | $193.16K derived: sum of 3 quarters · filed 2015-07-10 | $193.16K 10-K · filed 2015-07-10 | |||||
| 2014-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-10 | $193.16K derived: sum of 2 quarters · filed 2015-04-10 | $193.16K 10-Q · filed 2015-04-10 | $193.16K 10-Q · filed 2014-04-11 | |||||
| 2013-11-30 | $193.16K 10-Q · filed 2015-01-12 | $193.16K 10-Q · filed 2015-01-12 | $193.16K 10-Q · filed 2014-01-13 |